KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Cost of Revenue: 2009-2024

Historic Cost of Revenue for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $312.1 million.

  • Incyte's Cost of Revenue rose 15.13% to $99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.4 million, marking a year-over-year increase of 15.72%. This contributed to the annual value of $312.1 million for FY2024, which is 22.38% up from last year.
  • Incyte's Cost of Revenue amounted to $312.1 million in FY2024, which was up 22.38% from $255.0 million recorded in FY2023.
  • In the past 5 years, Incyte's Cost of Revenue ranged from a high of $312.1 million in FY2024 and a low of $131.3 million during FY2020.
  • Moreover, its 3-year median value for Cost of Revenue was $255.0 million (2023), whereas its average is $258.0 million.
  • Data for Incyte's Cost of Revenue shows a peak YoY soared of 37.09% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Incyte's Cost of Revenue stood at $131.3 million in 2020, then increased by 14.97% to $151.0 million in 2021, then spiked by 37.09% to $207.0 million in 2022, then grew by 23.19% to $255.0 million in 2023, then increased by 22.38% to $312.1 million in 2024.